Thomas Y. Shih

5.9k citations

61 papers · 5.1k indexed · 1 hit paper · h-index 37

Molecular Biology top 2%
Genetics top 1%
Oncology top 2%
Immunology top 5%
Cell Biology top 5%

Co-authors: Edward M. Scolnick Howard A. Young Maureen O. Weeks Ronald Ellis Douglas R. Lowy Alex G. Papageorge Gerald D. Fasman Linda S. Ulsh
Topics: Virus-based gene therapy research (27 papers)RNA Interference and Gene Delivery (17 papers)Cancer-related Molecular Pathways (16 papers)
Cited by: Genetics Molecular Biology Oncology
Journals: Nature Science Cell
Partner nations: United States Japan Israel

In The Last Decade

Thomas Y. Shih

61 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes

1981 644 citations Ronald Ellis, Thomas Y. Shih et al. Nature profile →

Peers

Countries citing papers authored by Thomas Y. Shih

Since Specialization

Citations

This map shows the geographic impact of Thomas Y. Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Y. Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Y. Shih more than expected).

Fields of papers citing papers by Thomas Y. Shih

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Y. Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Y. Shih. The network helps show where Thomas Y. Shih may publish in the future.

Co-authorship network of co-authors of Thomas Y. Shih

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Y. Shih. A scholar is included among the top collaborators of Thomas Y. Shih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Y. Shih. Thomas Y. Shih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Resistance of NIH3T3 Cells to v-fes Transformation Induced by a Dominant Negative H-ras Mutant 1993 ·Experimental Cell Research ·Yoshifumi Ogiso,(unknown),(unknown),Thomas Y. Shih,Noboru Kuzumaki	8
2	Biological activity of a K-ras mutant that contains the 12R/59T/116Y mutations 1993 ·Cancer Letters ·Yoshifumi Ogiso,Yu‐Wen Hwang,Thomas Y. Shih,Noboru Kuzumaki	3
3	Induction and progression of the transformed phenotype in cloned rat embryo fibroblast cells: Studies employing type 5 adenovirus and wild‐type and mutant Ha‐ras oncogenes 1992 ·Molecular Carcinogenesis ·John F. Boylan,Thomas Y. Shih,Paul B. Fisher,Stephen G. Zimmer	8
4	Tumorigenicity, metastasis and suppression of MHC class-I expression in murine fibroblasts transformed by mutantv-ras deficient in GTP binding 1991 ·International Journal of Cancer ·Youyong Lu,Donald G. Blair,Shraga Segal,Thomas Y. Shih,David J. Clanton	11
5	Neutralizing Monoclonal Antibody Against Ras Oncogene Product p21 Which Impairs Guanine Nucleotide Exchange 1987 ·Molecular and Cellular Biology ·Seisuke Hattori,David J. Clanton,Takaya Satoh,Shun Nakamura,Yoshito Kaziro,Masao Kawakita,Thomas Y. Shih	17
6	Interaction of ras Oncogene Product p21 with Guanine Nucleotides1 1987 ·The Journal of Biochemistry ·Masato Hoshino,David J. Clanton,Thomas Y. Shih,Masao Kawakita,Seisuke Hattori	30
7	Structural significance of the GTP-binding domain of ras p21 studied by site-directed mutagenesis. 1987 ·Molecular and Cellular Biology ·David J. Clanton,Youyong Lu,Donald G. Blair,Thomas Y. Shih	48
8	Revertants of Ha-MuSV-transformed MDCK cells express reduced levels of p21 and possess a more normal phenotype 1986 ·Experimental Cell Research ·Frederick J. Darfler,Thomas Y. Shih,Michael C. Lin	11
9	The ras oncogene product p21 is not a regulatory component of adenylate cyclase 1985 ·Nature ·Suzanne K. Beckner,Seisuke Hattori,Thomas Y. Shih	179
10	Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs. 1984 ·Molecular and Cellular Biology ·Linda S. Ulsh,Thomas Y. Shih	52
11	Nucleotide Sequence of the p21 Transforming Protein of Harvey Murine Sarcoma Virus 1982 ·Science ·Ravi Dhar,Ronald Ellis,Thomas Y. Shih,Stephen Oroszlan,Bruce A. Shapiro,Jacob V. Maizel,Douglas R. Lowy,Edward M. Scolnick	244
12	Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus 1979 ·Virology ·Thomas Y. Shih,Maureen O. Weeks,Howard A. Young,Edward M. Scolnick	234
13	Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses 1979 ·Proceedings of the National Academy of Sciences ·Edward M. Scolnick,Alex G. Papageorge,Thomas Y. Shih	255
14	Comparison of the genomic organization of Kirsten and Harvey sarcoma viruses 1978 ·Journal of Virology ·Thomas Y. Shih,D. R. Williams,Maureen O. Weeks,Jean Maryak,William C. Vass,Edward M. Scolnick	87
15	Heteroduplex analysis of the sequence relations between the RNAs of mink cell focus-inducing and murine leukemia viruses 1978 ·Journal of Virology ·Yueh‐hsiu Chien,Inder M. Verma,Thomas Y. Shih,Edward M. Scolnick,Norman Davidson	76
16	Steroid induction of mouse mammary tumor virus: effect upon synthesis and degradation of viral RNA 1977 ·Journal of Virology ·Howard A. Young,Thomas Y. Shih,E M Scolnick,Wade P. Parks	109
17	Chemical linkage of nucleic acids to neutral and phosphorylated cellulose powders and isolation of specific sequences by affinity chromatography 1974 ·Biochemistry ·Thomas Y. Shih,Malcolm A. Martin	34
18	A General Method of Gene Isolation 1973 ·Proceedings of the National Academy of Sciences ·Thomas Y. Shih,Malcolm A. Martin	17
19	Circular dichroism studies of histone-deoxyribonucleic acid complexes. Comparison of complexes with histone I (f-1), histone IV (f2al), and their mixtures 1972 ·Biochemistry ·Thomas Y. Shih,Gerald D. Fasman	52
20	Studies on the structure of metaphase and interphase chromatin of Chinese hamster cells by circular dichroism and thermal denaturation 1972 ·Biochemistry ·Thomas Y. Shih,Robert S. Lake	45

About Thomas Y. Shih

Thomas Y. Shih is a scholar working on Oncology, Genetics and Molecular Biology, having authored 61 papers that have together received 5.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (27 papers), RNA Interference and Gene Delivery (17 papers) and Cancer-related Molecular Pathways (16 papers). The work is most often cited by research in Genetics (1.6k citations), Molecular Biology (3.9k citations) and Oncology (1.4k citations). Thomas Y. Shih has collaborated with scholars based in United States, Japan and Israel. Frequent co-authors include Edward M. Scolnick, Howard A. Young, Maureen O. Weeks, Ronald Ellis, Douglas R. Lowy, Alex G. Papageorge, Gerald D. Fasman, Linda S. Ulsh, Deborah DeFeo and James Bonner. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact